⌘K

Apellis Pharmaceuticals, Inc. (APLS)

$29.26 -1.08% $-0.32 Healthcare

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy (GA) in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases. It also develops EMPAVELI (systemic pegcetacoplan) for the treatment of cold agglutinin disease (CAD), and hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) in hematology; C3 glomerulopathy (C3G), and immune complex membranoproliferative glomerulonephritis (IC-MPGN) in nephrology; and amyotrophic lateral sclerosis (ALS) in neurology. In addition, the company develops APL-2006, a bispecific C3 and VEGF inhibitor for treating complement-mediated disorders; APL-1030, a C3 inhibitor for the treatment of multiple neurodegenerative diseases; and the combination of EMPAVELI and a small interfering RNA, or siRNA for reducing the production of C3 proteins by the liver. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) to co-develop pegcetacoplan; and a research collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. Apellis Pharmaceuticals, Inc. was incorporated in 2009 and is based in Waltham, Massachusetts.

Market cap

$3.64B

CEO

Dr. Cedric Francois M.D., Ph.D.

Full time employees

476.00

Headquarters

Waltham, MA

IPO Date

Nov 09, 2017

Price-to-earnings (PE) Ratio

-14.41

Earnings-per-share (EPS)

$-2.03

Cash ratio (TTM)

2.07

Current ratio (TTM)

4.36

Net profit margin (TTM)

-35.99%

PE ratio (TTM)

-14.65

PEG ratio (TTM)

1.45

Price-to-book ratio (TTM)

15.46

Price-to-sales ratio (TTM)

5.29

Quick ratio (TTM)

3.73

Return on assets (TTM)

-27.73%

Return on equity (TTM)

-103.92%

Similar stocks (8)

Madrigal Pharmaceuticals, Inc.

MDGL

$339.04 -0.18% $-0.62

Neutral

Blueprint Medicines Corporation

BPMC

$96.62 -3.25% $-3.25

Neutral

Immunovant, Inc.

IMVT

$29.27 -6.01% $-1.87

Neutral

Akero Therapeutics, Inc.

AKRO

$32.38 -2.00% $-0.66

Uptrend

Day One Biopharmaceuticals, Inc.

DAWN

$15.64 -1.39% $-0.22

Neutral

Amylyx Pharmaceuticals, Inc.

AMLX

$6.24 -11.24% $-0.79

Neutral

Inozyme Pharma, Inc.

INZY

$3.76 -6.00% $-0.24

Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.68 -16.93% $-0.54

Neutral

ETF Exposure (28)

Jacob Forward ETF

JFWD

2.59%

$12.10 -2.95% $-0.37

Uptrend

Direxion Daily S&P Biotech Bull 3X Shares

LABU

0.577847014%

$131.90 -8.64% $-12.47

Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.35%

$23.77 -2.42% $-0.59

Uptrend

iShares Biotechnology ETF

IBB

0.28312%

$144.36 -2.27% $-3.36

Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.10693261840846327%

$62.76 -5.40% $-3.58

Uptrend

iShares Russell Mid-Cap Growth ETF

IWP

0.0983%

$131.20 -0.54% $-0.71

Uptrend

iShares Morningstar Small-Cap Growth ETF

ISCG

0.09442%

$52.74 -1.35% $-0.72

Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.086659993%

$27.60 -1.55% $-0.44

Uptrend

Schwab U.S. Mid-Cap ETF

SCHM

0.0741239193%

$29.16 -1.09% $-0.32

Uptrend

Vanguard Small Cap Index Fund

NAESX

0.07%

$122.72 1.19% $1.44

Uptrend

Invesco Russell 1000 Equal Weight ETF

EQAL

0.063%

$50.57 -0.73% $-0.37

Uptrend

JPMorgan BetaBuilders U.S. Mid Cap Equity ETF

BBMC

0.06%

$101.51 -0.94% $-0.96

Uptrend

iShares U.S. Healthcare ETF

IYH

0.05385%

$62.18 -1.41% $-0.89

Neutral

iShares Morningstar Small-Cap ETF

ISCB

0.04811%

$62.50 -1.39% $-0.88

Uptrend

iShares ESG Aware MSCI USA Small-Cap ETF

ESML

0.0335%

$44.63 -1.35% $-0.61

Uptrend

Fidelity MSCI Health Care Index ETF

FHLC

0.032968420000000005%

$70.21 -1.45% $-1.03

Neutral

iShares Russell Mid-Cap ETF

IWR

0.0248%

$92.81 -0.77% $-0.72

Uptrend

iShares Russell 1000 Growth ETF

IWF

0.01049%

$398.79 0.08% $0.31

Uptrend

Vanguard ESG U.S. Stock ETF

ESGV

0.01%

$106.49 -0.25% $-0.27

Uptrend

First Trust Nasdaq BuyWrite Income ETF

FTQI

0.01%

$21.09 -0.19% $-0.04

Uptrend

Fidelity Nasdaq Composite Index ETF

ONEQ

0.01%

$75.82 -0.41% $-0.31

Uptrend

Schwab 1000 Index ETF

SCHK

0.0060314541%

$28.84 -0.55% $-0.16

Uptrend

Schwab U.S. Broad Market ETF

SCHB

0.0057845547%

$23.18 -0.56% $-0.13

Uptrend

iShares Dow Jones U.S. ETF

IYY

0.00559%

$146.02 -0.24% $-0.36

Uptrend

iShares Russell 1000 ETF

IWB

0.00552%

$328.79 -0.32% $-1.06

Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

0.00526%

$131.55 -0.45% $-0.59

Uptrend

iShares Russell 3000 ETF

IWV

0.00501%

$342.01 -0.45% $-1.55

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

3.759e-4%

$35.93 -0.53% $-0.19

Uptrend

Downtrend

Similar stocks (8)

Madrigal Pharmaceuticals, Inc.

MDGL

$339.04 -0.18% $-0.62

Neutral

Blueprint Medicines Corporation

BPMC

$96.62 -3.25% $-3.25

Neutral

Immunovant, Inc.

IMVT

$29.27 -6.01% $-1.87

Neutral

Akero Therapeutics, Inc.

AKRO

$32.38 -2.00% $-0.66

Uptrend

Day One Biopharmaceuticals, Inc.

DAWN

$15.64 -1.39% $-0.22

Neutral

Amylyx Pharmaceuticals, Inc.

AMLX

$6.24 -11.24% $-0.79

Neutral

Inozyme Pharma, Inc.

INZY

$3.76 -6.00% $-0.24

Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.68 -16.93% $-0.54

Neutral

ETF Exposure (28)

Jacob Forward ETF

JFWD

2.59%

$12.10 -2.95% $-0.37

Uptrend

Direxion Daily S&P Biotech Bull 3X Shares

LABU

0.577847014%

$131.90 -8.64% $-12.47

Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.35%

$23.77 -2.42% $-0.59

Uptrend

iShares Biotechnology ETF

IBB

0.28312%

$144.36 -2.27% $-3.36

Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.10693261840846327%

$62.76 -5.40% $-3.58

Uptrend

iShares Russell Mid-Cap Growth ETF

IWP

0.0983%

$131.20 -0.54% $-0.71

Uptrend

iShares Morningstar Small-Cap Growth ETF

ISCG

0.09442%

$52.74 -1.35% $-0.72

Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.086659993%

$27.60 -1.55% $-0.44

Uptrend

Schwab U.S. Mid-Cap ETF

SCHM

0.0741239193%

$29.16 -1.09% $-0.32

Uptrend

Vanguard Small Cap Index Fund

NAESX

0.07%

$122.72 1.19% $1.44

Uptrend

Invesco Russell 1000 Equal Weight ETF

EQAL

0.063%

$50.57 -0.73% $-0.37

Uptrend

JPMorgan BetaBuilders U.S. Mid Cap Equity ETF

BBMC

0.06%

$101.51 -0.94% $-0.96

Uptrend

iShares U.S. Healthcare ETF

IYH

0.05385%

$62.18 -1.41% $-0.89

Neutral

iShares Morningstar Small-Cap ETF

ISCB

0.04811%

$62.50 -1.39% $-0.88

Uptrend

iShares ESG Aware MSCI USA Small-Cap ETF

ESML

0.0335%

$44.63 -1.35% $-0.61

Uptrend

Fidelity MSCI Health Care Index ETF

FHLC

0.032968420000000005%

$70.21 -1.45% $-1.03

Neutral

iShares Russell Mid-Cap ETF

IWR

0.0248%

$92.81 -0.77% $-0.72

Uptrend

iShares Russell 1000 Growth ETF

IWF

0.01049%

$398.79 0.08% $0.31

Uptrend

Vanguard ESG U.S. Stock ETF

ESGV

0.01%

$106.49 -0.25% $-0.27

Uptrend

First Trust Nasdaq BuyWrite Income ETF

FTQI

0.01%

$21.09 -0.19% $-0.04

Uptrend

Fidelity Nasdaq Composite Index ETF

ONEQ

0.01%

$75.82 -0.41% $-0.31

Uptrend

Schwab 1000 Index ETF

SCHK

0.0060314541%

$28.84 -0.55% $-0.16

Uptrend

Schwab U.S. Broad Market ETF

SCHB

0.0057845547%

$23.18 -0.56% $-0.13

Uptrend

iShares Dow Jones U.S. ETF

IYY

0.00559%

$146.02 -0.24% $-0.36

Uptrend

iShares Russell 1000 ETF

IWB

0.00552%

$328.79 -0.32% $-1.06

Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

0.00526%

$131.55 -0.45% $-0.59

Uptrend

iShares Russell 3000 ETF

IWV

0.00501%

$342.01 -0.45% $-1.55

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

3.759e-4%

$35.93 -0.53% $-0.19

Uptrend